Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.39 - $3.5 $32,850 - $48,107
-13,745 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$2.86 - $4.33 $9,975 - $15,103
3,488 Added 34.01%
13,745 $41,000
Q4 2020

Feb 16, 2021

SELL
$2.93 - $4.3 $225 - $331
-77 Reduced 0.75%
10,257 $35,000
Q2 2020

Aug 14, 2020

BUY
$1.99 - $4.4 $20,564 - $45,469
10,334 New
10,334 $43,000

About Aptinyx Inc.


  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.